Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

InvOpps IV US, L.P. — Oyster Point Pharma, Inc. insider: 2 transactions · InsiderLens

Home / Insiders / InvOpps IV US, L.P.

InvOpps IV US, L.P.

Director at Oyster Point Pharma, Inc. · on record since Oct 30, 2019
10% owner at Oyster Point Pharma, Inc. · on record since Oct 30, 2019

Insider trading activity of InvOpps IV US, L.P.

Transactions on record: 2; since May 21, 2020

Open-market buys: 2; $5M

Open-market sells: 0

Companies traded: 1; last filing May 21, 2020

Figures computed from official regulatory filings — methodology.

Companies where InvOpps IV US, L.P. has traded

Oyster Point Pharma, Inc.2 tx · $5M · May 21, 2020

Track record of InvOpps IV US, L.P.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of InvOpps IV US, L.P.

Co-insiders of InvOpps IV US, L.P.

Ackermann MichaelOyster Point Pharma, Inc.
ATIEH MICHAEL GOyster Point Pharma, Inc.
BARRIS PETER JOyster Point Pharma, Inc.
BASKETT FORESTOyster Point Pharma, Inc.
Behbahani AliOyster Point Pharma, Inc.
Clare OzawaOyster Point Pharma, Inc.
Eliades George ChristopherOyster Point Pharma, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Falcon Vision LLCOyster Point Pharma, Inc.

Florence Anthony A. Jr.Oyster Point Pharma, Inc.

InvOpps GP IV, L.L.C.Oyster Point Pharma, Inc.

InvOpps IV, L.P.Oyster Point Pharma, Inc.

KERINS PATRICK JOyster Point Pharma, Inc.

KKR Associates HCSG L.P.Oyster Point Pharma, Inc.

KKR & Co. L.P.Oyster Point Pharma, Inc.

KKR Fund Holdings GP LtdOyster Point Pharma, Inc.

KKR Fund Holdings L.P.Oyster Point Pharma, Inc.

KKR Group Holdings Corp.Oyster Point Pharma, Inc.

KKR HCSG GP LLCOyster Point Pharma, Inc.

KKR Healthcare Strategic Growth Fund L.P.Oyster Point Pharma, Inc.

KKR Management LLCOyster Point Pharma, Inc.

Kleiner Perkins Caufield & Byers XIV, LLCOyster Point Pharma, Inc.

KPCB XIV Associates, LLCOyster Point Pharma, Inc.

KPCB XIV Founders Fund, LLCOyster Point Pharma, Inc.

KRAVIS HENRY ROyster Point Pharma, Inc.

LAINOVIC SACHAOyster Point Pharma, Inc.

LINK WILLIAM J PHDOyster Point Pharma, Inc.

Lochner DanielOyster Point Pharma, Inc.

MOTT DAVID MOyster Point Pharma, Inc.

Murray Mark AnthonyOyster Point Pharma, Inc.

Nau JeffreyOyster Point Pharma, Inc.

NEA 14 GP, LTDOyster Point Pharma, Inc.

NEA Partners 14, L.P.Oyster Point Pharma, Inc.

New Enterprise Associates 14, L.P.Oyster Point Pharma, Inc.

OYSTER POINT PHARMA I, LLCOyster Point Pharma, Inc.

ROBERTS GEORGE ROyster Point Pharma, Inc.

SANDELL SCOTT DOyster Point Pharma, Inc.

Santel Donald JOyster Point Pharma, Inc.

Snisarenko JohnOyster Point Pharma, Inc.

Sonsini Peter W.Oyster Point Pharma, Inc.

Tsai BenjaminOyster Point Pharma, Inc.

Versant Side Fund IV, L.P.Oyster Point Pharma, Inc.

Versant Vantage I GP-GP, LLCOyster Point Pharma, Inc.

Versant Vantage I GP, L.P.Oyster Point Pharma, Inc.

Versant Vantage I, L.P.Oyster Point Pharma, Inc.

Versant Venture Capital IV, L.P.Oyster Point Pharma, Inc.

Versant Venture Capital VI, L.P.Oyster Point Pharma, Inc.

Versant Ventures IV, LLCOyster Point Pharma, Inc.

Versant Ventures VI GP-GP, LLCOyster Point Pharma, Inc.

Versant Ventures VI GP, L.P.Oyster Point Pharma, Inc.

Vida Ventures, LLCOyster Point Pharma, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Oyster Point Pharma, Inc.	May 21, 2020	Buy	59,178	28.00 USD	$1.7M	SEC
Oyster Point Pharma, Inc.	May 21, 2020	Buy	119,393	28.00 USD	$3.3M	SEC